Q2 2024—Side 2

Q2 2024Financial highlights Q2 2024  Revenue DKK 332.2 million (DKK 255.5 million) corresponding to a revenue increase of 30.0%.  Adjusted EBITDA DKK 36.7 million (DKK 27.5 million). Adjusted EBITDA margin was 11.1% (10.8%).  Adjusted EBIT of DKK 28.0 million (DKK 22.3 million). Adjusted EBIT margin was 8.4% (8.7%).  Non-recurring items had a total impact of DKK 0.0 million (DKK 2.8 million).  EBIT of DKK 28.0 million (DKK 19.5 million), corresponding to an EBIT margin of 8.4% (7.6%).  Net profit of DKK 18.9 million (DKK 12.2 million).  Free cash flow was DKK 25.8 million (DKK -1.6 million).  Cash conversion ratio was 94.8% (48.8%). Financial highlights H1 2024  Revenue DKK 624.7 million (DKK 519.4 million) corresponding to a revenue increase of 20.3%.  Adjusted EBITDA of DKK 61.1 million (DKK 45.5 million). Adjusted EBITDA margin was 9.8% (8.8%).  Adjusted EBIT of DKK 43.8 million (DKK 35.4 million). Adjusted EBIT margin was 7.0% (6.8%).  Non-recurring items had a negative impact of DKK 0.0 million (DKK 4.7 million).  EBIT of DKK 43.8 million (DKK 30.9 million), corresponding to an EBIT margin of 7.0% (5.9%).  Net profit of DKK 25.9 million (DKK 17.6 million).  Free cash flow was DKK 38.4 million (DKK -37.4 million).  Full-year guidance for the financial year 2024 is revenue in the range DKK 1,125-1,200 million with earnings (adjusted EBIT) in the range of DKK 70-90 million. Contact For further information, please contact: CEO Torben Paulin +45 21210464 CFO Thomas Hjannung +45 25174233 IR Contact – ir@tcmgroup.dk TCM Group A/S, Skautrupvej 16, DK-7500 Holstebro, Company reg. (CVR) no: 37291269 Page 2 of 21Side 1Side 3